Indi Molecular
Culver City, US · Founded 2013 · Delaware corporation · 3 known investors
Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech. The company focuses on drug candidates targeting ovarian and pancreatic cancer.
BiotechDeep TechMedical Devices
Founders & leadership
LH
Leroy HoodDirector
AJ
Andreas JurgeitDirector
JH
James HeathDirector
HA
Heather AgnewExecutive Officer
AL
Albert LudererExecutive Officer, Director
DF
Douglas FisherDirector
DC
Darren CaiDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$4.5MraisedJun 2017 · 6 investors · BiotechnologyRule 506(b)
▶$4.5MraisedJun 2017 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Leroy HoodDirector
- Andreas JurgeitDirector
- James HeathDirector
- Heather AgnewExecutive Officer
- Albert LudererExecutive Officer, Director
- Douglas FisherDirector
- Darren CaiDirector
- Amount sold
- $4.5M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Indi Molecular Raises $11.5M in Series A Funding - FinSMEsfinsmes.com · 2017
- BioCentury - Indi Molecular raises $11.5M in series A roundbiocentury.com · 2017
- Indi Molecular Raises $11.5M Series A to Accelerate PCC Platform Developmentglobenewswire.com · 2017
- Indi Molecular Launches With $1.5 Million Seed Round Led by Interwest Partnersfinance.yahoo.com · 2013
- Indi Molecular - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com